By InvitationNot Applicable

Evaluating the Efficacy of Intravenous Acetaminophen (IV Tylenol) in Reducing Pain and Agitation in Pediatric Patients Undergoing Elective Tonsillectomy and/or Adenoidectomy

United States20 participantsStarted 2025-04-21

Plain-language summary

MetroHealth's main campus administers IV Tylenol as part of its pain management protocol for elective tonsillectomy/adenoidectomy, whereas Parma campus does not. Comparing these practices provides an opportunity to evaluate the benefits of IV Tylenol for pain, agitation, and associated secondary outcomes in this population. The pain/agitation would be assessed with a validated tool PAED and FLACC

Who can participate

Age range8 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects pediatric patients aged ≤7 years, observed by study team who will complete the scales * Undergoing elective tonsillectomy and adenoidectomy. Exclusion Criteria: * Pre-existing neurological or developmental disorders impacting pain/agitation scores

What they're measuring

Pain Assessment

Timeframe: * "Baseline" * "Perioperative/Periprocedural"

Trial details

NCT IDNCT07576985

SponsorMetroHealth Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-05-01

View on ClinicalTrials.gov More Tonsillectomy trials